Clinical Trial Update: Study Evaluating the Pharmacokinetics of Mavacamten in Healthy Adult Chinese Subjects [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetics study of mavacamten in healthy adult Chinese subjects has completed, with results posted in 2024. The sponsor listed is LianBio LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy

Drugs mentioned

• CAMZYOS (MAVACAMTEN)

Snippet

Sponsor: LianBio LLC | Conditions: Hypertrophic Cardiomyopathy | Phase 1 | Status: COMPLETED | Results posted: 2024-07-25